US74112D1019
US74112D1019
Prestige Consumer Healthcare In
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.28B EUR | 2.24B EUR | 2.8B EUR | 2.92B EUR |
Enterprise Value | 4.25B EUR | 4.22B EUR | 3.79B EUR | 3.94B EUR |
Valuation Multiples | ||||
Trailing P/E | 13.51x | 13.02x | 14.74x | 21.41x |
Forward P/E | 9.49x | -- | -- | -- |
Price to Sales | 2.07x | 2.03x | 2.58x | 3.62x |
Price to Book | 1.19x | 1.17x | 1.49x | 1.6x |
EV/Revenue | 3.84x | 3.82x | 3.48x | 4.88x |
EV/EBITDA | 13.05x | 13.49x | 11.43x | 15.96x |
Price to FCF (P/FCF) | 15.45x | 9.51x | 11.38x | 13.98x |
EV/FCF | 28.71x | 17.92x | 15.36x | 18.85x |
FCF Yield | 6.47% | 10.51% | 8.79% | 7.15% |